SEARCH

SEARCH BY CITATION

References

  • 1
    Antonio S, Larghia P, Mancinob A et al. Macrophage polarization in tumor progression. Semin Cancer Biol 2008;18:34955.
  • 2
    MacLauchlan S, Skokos EA, Meznarich N et al. Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9. J Leukoc Biol 2009;85:61726.
  • 3
    van den Berg TK, van Beek EM, Buhring HJ et al. A nomenclature for signal regulatory protein family members. J Immunol 2005;175:77889.
  • 4
    Kharitonenkov A, Chen Z, Sures I et al. A family of proteins that inhibit signaling through tyrosine kinase receptors. Nature 1997;386:1816.
  • 5
    Johansen ML, Brown EJ. Dual regulation of SIRP alpha phosphorylation by integrins and CD47. J Biol Chem 2007;282:2421930.
  • 6
    Seiffert M, Brossart P, Cant C et al. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(−) hematopoietic cells. Blood 2001;97:27419.
  • 7
    Latour S, Tanaka H, Demeure C et al. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol 2001;167:254754.
  • 8
    Inagaki K, Yamao T, Noguchi T et al. SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility. J EMBO 2000;19:672131.
  • 9
    Seiffert M, Cant C, Chen Z et al. Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counter receptor CD47. Blood 1999;94:363343.
  • 10
    Veillette A, Thibaudeau E, Latour S. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. J Bio Chem 1998;273:2271928.
  • 11
    Adams S, van der Laan LJ, Vernon-Wilson E et al. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J Immunol 1998;161:18539.
  • 12
    Avice MN, Rubio M, Sergerie M et al. Role of CD47 in the induction of human naive T cell anergy. J Immunol 2001;167:245968.
  • 13
    Demeure CE, Tanaka H, Mateo V et al. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J Immunol 2000;164:21939.
  • 14
    Avice MN, Rubio M, Sergerie M et al. CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors. J Immunol 2000;165:462431.
  • 15
    Armant M, Avice MN, Hermann P et al. CD47 ligation selectively downregulates human interleukin 12 production. J Exp Med 1999;190:117582.
  • 16
    Jaiswal S, Chao MP, Majeti R et al. Macrophages as mediators of tumor immunosurveillance. Trends Immunol 2010;31:2129.
  • 17
    Jattela M. Heat shock proteins as cellular lifeguards. Ann Med 1999;31:26171.
  • 18
    Blachere NE, Li Z, Chandawarkar RY et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytoxic T-lymphocytes response and tumor immunity. J Exp Med 1997;186:131527.
  • 19
    Tamura Y, Peng P, Liu K et al. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997;278:11720.
  • 20
    Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 1993;178:13916.
  • 21
    Tokuda Y, Tsuji M, Yamazaki M et al. Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo. Antimicrob Agents Chemother 1993;37:222830.
  • 22
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:6805.
  • 23
    Tamura Y, Peng P, Liu K et al. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1999;278:11720.
  • 24
    Tameike A, Konomi M, Sato M et al. Structural ejects of lanoconazole on the hyphal growth of Trichophyton rubrum. Jpn J Med Mycol 1996;37:25161.
  • 25
    Kunisch R, Kamal E, Lewin A. The role of the mycobacterial DNA-binding protein 1 (MDP1) from Mycobacterium bovis BCG in host cell interaction. BMC Microbiol 2012;165:111.
  • 26
    Zaccaro Scelza MF, Lima Oliveira LR, Carvalho FB, Côrte-Real Faria S. In vitro evaluation of macrophage viability after incubation inorange oil, eucalyptol, and chloroform. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:e24e7.
  • 27
    Broderick L, Bankert RB. Membrane-associated TGF-beta1 inhibits human memory T cell signaling in malignant and nonmalignant inflammatory microenvironments. J Immunol 2006;177:30828.
  • 28
    Irandoust M, Alvarez Zarate J, Hubeek I, van Beek EM. Engagement of SIRPa inhibits growth and induces programmed cell death in acute myeloid leukemia cells. PLoS ONE 2013;8:e52143.
  • 29
    Li X, Tai HH. Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1(MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells. PLoS ONE 2013;8:e54073.
  • 30
    Ye L, Liu X, Rout SN et al. The MHC class II-associated invariant chain interacts with the neonatal Fcγ receptor and modulates its trafficking to endosomal/lysosomal compartments. J Immunol 2008;181:257285.
  • 31
    Mantovani A, Allavena P, Sozzani S et al. Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol 2004;14:15560.
  • 32
    Bradford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 1976;72:24854.
  • 33
    Allavena P, Sica A, Solinas G et al. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008;66:19.
  • 34
    Timms JF, Carlberg K, Gu H et al. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol Cell Biol 1998;18:383850.
  • 35
    Chao MP, Alizadeh AA, Tang C et al. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res 2011;71:137484.
  • 36
    Zhao B, Wang Y, Zhang Y et al. TAT-mediated gp96 transduction to APCs enhances gp96-induced antiviral and antitumor T cell responses. Vaccine 2013;31:545552.
  • 37
    Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:2335.